Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the quarter and year ended December 31, 2025, after the close ...

New validated automated workflows enable higher-throughput, more reproducible NGS library preparation using on-deck fragmentation, ligation, and auto-normalization.

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

Princeton, New Jersey Thursday, February 19, 2026, 11:00 Hrs [IST] ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Europe Genomic Cancer Panel and Profiling Market size by value at USD 2.62 billion in 2023. During ...

I am the Co-founder and CEO of HaystackAnalytics, a life sciences deep-tech company working in clinical genomics. At Haystack ...

MedGenome has announced the launch of MetaSeq, an advanced blood test designed to support faster and more comprehensive detection of bloodstream infections (BSI). MetaSeq uses metagenomic ...

Introduction While pathogen genomics using next-generation sequencing (NGS) has been recommended by the WHO as an essential ...

This eBook explores quality and analytics in the contexts of laboratory digitization, raw-materials monitoring, and modern ...